Amory John Kenneth 4
4 · Clarus Therapeutics Holdings, Inc. · Filed Jun 9, 2022
Insider Transaction Report
Form 4
Amory John Kenneth
Director
Transactions
- Award
Common Stock
2022-06-07+1,922→ 5,766 total - Award
Stock Option (Right to Buy)
2022-06-07+4,805→ 4,805 totalExercise: $0.43Exp: 2032-06-06→ Common Stock (4,805 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 1,922 shares on 06/07/2022, which vests in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting.
- [F2]These options were granted under the 2021 Plan and vest in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting.